EMIT Imaging specialises in advanced three-dimensional fluorescence imaging systems for preclinical research.
The company is a recognised developer and manufacturer of Cryo-Fluorescence Tomography (CFT) technology, delivering high-resolution, high-sensitivity volumetric imaging to support biological and drug research workflows. EMIT’s Xerra™ imaging platform and associated services are applied in drug distribution studies, protein expression analysis, and other preclinical research areas where reliable, detailed imaging data is required
